John Cooper has served as a Director on Rockwell Medical's Board since September 2017.
Mr. Cooper’s career spans over 30 years of senior executive experience managing publicly-traded companies in the life sciences industry. He has played key leadership roles building companies with transformational medical technologies, including the first FDA approved synthetic peptide-containing pulmonary surfactant for premature infants with severe respiratory disease and the second FDA approved blood diagnostic test for HIV. Mr. Cooper has significant experience in corporate and organization development, raising capital, mergers and acquisitions, strategic alliances, investor relations, and corporate governance. Over his career, Mr. Cooper has raised approximately $1 billion in capital through various financing and strategic transactions. Currently, Mr. Cooper provides corporate development and financial advisory services to emerging public and private companies in the life sciences industry.
Mr. Cooper held executive leadership positions for Windtree Therapeutics (formerly Discovery Laboratories), a specialty biopharmaceutical company focused on respiratory therapeutics, from 2001 to 2016. His roles included President, Chief Executive Officer and Member of the Board of Directors, President and Chief Financial Officer, Executive Vice President and Chief Financial Officer. Prior to Discovery Labs, Mr. Cooper served as Senior Vice President and Chief Financial Officer at Chrysalis International Corporation (acquired by Phoenix Life Sciences) and its predecessor DNX Corporation, where he managed its initial public offering and negotiated and integrated several strategic acquisitions. Previously, Mr. Cooper served in senior financial management and executive committee roles at ENI Diagnostics (acquired by Pharmacia AB).
Mr. Cooper received his B.S. in Commerce from Rider University and holds a CPA designation.
What is John G. Cooper's net worth?
The estimated net worth of John G. Cooper is at least $118.54 thousand as of November 18th, 2025. Cooper owns 14,037 shares of Rockwell Medical stock worth more than $118,542 as of September 28th. This net worth evaluation does not reflect any other assets that Cooper may own. Learn More about John G. Cooper's net worth.
How do I contact John G. Cooper?
Has John G. Cooper been buying or selling shares of Rockwell Medical?
John G. Cooper has not been actively trading shares of Rockwell Medical during the last quarter. Most recently, John G. Cooper sold 507 shares of the business's stock in a transaction on Tuesday, November 18th. The shares were sold at an average price of $8.70, for a transaction totalling $4,410.90. Following the completion of the sale, the director now directly owns 14,037 shares of the company's stock, valued at $122,121.90. Learn More on John G. Cooper's trading history.
Who are Rockwell Medical's active insiders?
Are insiders buying or selling shares of Rockwell Medical?
During the last year, insiders at the sold shares 2 times. They sold a total of 793 shares worth more than $7,814.30. The most recent insider tranaction occured on November, 18th when Director
John G Cooper sold 507 shares worth more than $4,410.90. Insiders at Rockwell Medical own 4.6% of the company.
Learn More about insider trades at Rockwell Medical. Information on this page was last updated on 11/18/2025.
